Relating To Medical Cannabis.
HB325 amends Hawaii’s medical cannabis patient and caregiver protections law to add explicit employment protections for registered medical cannabis card holders. The bill would prohibit employers from discriminating in hiring, termination, or other terms and conditions of employment based solely on a person’s status as a medical cannabis registry card holder, or on a positive cannabis drug test, unless the employee was impaired during work hours or in a potentially dangerous occupation. It also preserves an employer’s ability to require medical evaluation when safety concerns arise and allows discipline for workplace use or possession of medical cannabis when impairment is present.
The bill also clarifies that schools and landlords may not penalize qualifying patients or caregivers solely for lawful participation in the medical cannabis program, subject to federal-law exceptions where benefits could be lost. It further states that a registered patient’s cannabis use should be treated like other physician-directed medication for purposes of medical care, including organ transplants, and should not by itself disqualify the patient from care. The measure retains and reorganizes existing protections for custody, visitation, and parenting time, barring presumptions of neglect or endangerment for conduct allowed under the medical cannabis law unless a specific danger to a minor is proven.
HB325 would significantly affect Hawaii employment law by creating a statutory anti-discrimination framework for medical cannabis patients, while carving out broad exceptions for safety-sensitive jobs. The bill exempts law enforcement, corrections, firefighters, lifeguards, emergency medical services personnel, workers who administer drugs, employees working with children or vulnerable populations, civil defense personnel, and workers operating vehicles, heavy machinery, public utilities, or other hazardous equipment. In potentially dangerous occupations, employers may use fit-for-duty testing as a risk-based assessment tool, and the bill also limits employer liability where cannabis impairment is the sole contributing factor to an injury or death.
The general sentiment reflected in the bill text is supportive of medical cannabis patients and focused on reducing uncertainty for employers and employees. The findings emphasize that medical cannabis is already legal in Hawaii, that many patients are registered, and that the lack of clear employment protections can lead to job loss and inconsistent court outcomes. The bill is framed as a balancing measure: it seeks to protect qualifying patients from discrimination while preserving workplace safety and employer compliance with federal law and licensing requirements.
The main points of contention are the scope of employment protections and the breadth of the exemptions. The bill draws a line between ordinary employment settings and safety-sensitive roles, which may be seen as necessary by employers and public-safety advocates but potentially too restrictive by patient advocates. Another likely issue is the interaction with federal law and employer drug-free workplace policies, since the bill repeatedly preserves exceptions where compliance could jeopardize federal or contractual benefits. No committee testimony or vote history was provided, so the broader political debate cannot be assessed from the available record.
HB325 would amend section 329-125.5 of the Hawaii Revised Statutes to expand and clarify protections for medical cannabis patients and caregivers, especially in employment. It would create an explicit anti-discrimination rule for employers, while preserving exceptions tied to federal law, contractual obligations, workplace impairment, and a long list of safety-sensitive occupations. The bill also reinforces existing protections for housing, education, medical care, and family-court-related matters, and it would add statutory language authorizing fit-for-duty testing in dangerous occupations and limiting employer liability in certain impairment-related incidents.
The bill appears generally supportive of medical cannabis patients and aimed at closing perceived gaps in current law. Its findings describe a need for clearer protections because patients may lose jobs despite lawful medical use, and because employers face uncertainty about how state and federal law interact. At the same time, the bill is written to reassure employers and public-safety stakeholders by preserving workplace safety rules, federal-law exceptions, and broad carveouts for hazardous jobs. No vote record or committee transcript was provided, so there is no direct evidence of organized opposition or support beyond the bill’s stated balancing approach.
The most notable contention is between patient employment protections and employer authority to maintain drug-free and safety-sensitive workplaces. Supporters of the bill would likely emphasize non-discrimination for lawful medical use, while opponents or cautious stakeholders may focus on impairment risks, liability concerns, and the difficulty of applying protections in dangerous occupations. The broad exemption list—covering police, corrections, firefighters, EMS, workers around children or vulnerable populations, and operators of vehicles or machinery—suggests that safety and operational risk are the central disputed issues. Federal preemption and the possibility of losing federal or licensing-related benefits also remain important limiting factors in the bill.